Abstract

A COMPREHENSIVE REVIEW OF PRODUCT LIFECYCLE MANAGEMENT IN THE PHARMACEUTICAL INDUSTRY

Jayshree Bagal*, Dr. Nimita Manocha, Gaurav Sarsodiya, Gyanendra Singh Patel

.

Abstract

In the pharmaceutical industry, Product Lifecycle Management (PLM) has emerged as a crucial tactic to guarantee the effective creation, control, and marketing of pharmaceuticals. The structure and phases of the pharmaceutical product lifecycle—from concept creation to market withdrawal—as well as the strategic approaches needed at each stage are the main topics of this review. It highlights how PLM is in line with quality standards including GMP, QMS, and CAPA protocols in addition to promoting timely innovation and regulatory compliance. The study also explores marketing methods that change depending on the stage of the product's lifetime and the difficulties in adjusting to sophisticated data systems, global outsourcing models, and shifting regulatory environments. Particular focus is placed on digital advancements, especially the rise of Digital Twin technology, which is transforming clinical research and medication development trials through the simulation of actual processes. Pharmacies may increase productivity, cut expenses, and launch safer, better goods faster by combining traditional lifecycle procedures with contemporary digital technologies. In order to optimize the lifecycle of pharmaceutical goods in the current global environment, this review offers a thorough overview of PLM, including information on its advantages, changing trends, and potential future research areas.

Keywords: Product lifecycle management, Stages of PLCM, Marketing strategies, Regulatory lifecycle management in pharma, Quality management and compliance, PLCM sustainability and future trend, Digital twins drug development.